# Evaluation Study of the Intestinal Microbiota and Quality of Life in Patients Suffering From IBS Treated With Bifidice

> **NCT05663060** · NA · COMPLETED · sponsor: **Istituto Clinico Humanitas** · enrollment: 8 (actual)

## Conditions studied

- Irritable Bowel Syndrome

## Interventions

- **DRUG:** Probiotic Formula

## Key facts

- **NCT ID:** NCT05663060
- **Lead sponsor:** Istituto Clinico Humanitas
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-13
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2024-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05663060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05663060, "Evaluation Study of the Intestinal Microbiota and Quality of Life in Patients Suffering From IBS Treated With Bifidice". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05663060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*